Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/004310 stock hub

KRX/004310 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/004310is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

221.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/004310

In the news

Latest news · KRX/004310

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E132.6

P25 12P50 23.1P75 39.5

ROE1.5

P25 -17.1P50 0.7P75 8.5

ROIC2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/004310 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

KRW

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	393
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7004310009
Last refreshed	2026-05-10
Market cap	KRW 221.4B
Price	KRW 8,000
Price currency	KRW
Rev Per Employee	275,153,879.26x
Sector	Healthcare
Sic	2834
Symbol	krx/004310
Website	https://www.hyundaipharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.64%
FCF yield	2.58%
P/B ratio	2.19x
P/E ratio	132.59x
P/S ratio	2.05x
PE Ratio10 Y	60.54x
PE Ratio5 Y	139.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.02%
EBITDA Margin	3.97%
FCF margin	5.28%
Gross margin	37.44%
Gross Profit	KRW 40.5B
Gross Profit Growth	3.64%
Gross Profit Growth Q	2.99%
Gross Profit Growth3 Y	-3.83%
Gross Profit Growth5 Y	-4.65%
Net Income	KRW 1.4B
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	-21.88%
Net Income Growth5 Y	-16.45%
Pretax Margin	1.06%
Profit Margin	1.31%
Profit Per Employee	KRW 3.6M
Profitable Years	1
ROA	0.93
Roa5y	0.16
ROCE	2.05
ROE	1.45
Roe5y	0.45
ROIC	2.04
Roic5y	-0.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.27%
Cagr15y	14.28%
Cagr1y	142.45%
Cagr20y	8.6%
Cagr3y	15.94%
Cagr5y	3.24%
Div CAGR10	-4.49%
Div CAGR3	-5.01%
Div CAGR5	0%
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	-21.42
EPS Growth5 Y	-14.34
OCF Growth10 Y	14.36%
OCF Growth3 Y	43.72%
Revenue Growth	5.75x
Revenue Growth Q	5.01x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.12x
Revenue Growth5 Y	-2.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.74
Assets	KRW 143.4B
Cash	KRW 14.6B
Current Assets	KRW 80.5B
Current Liabilities	KRW 36.6B
Debt	KRW 20.7B
Debt EBITDA	KRW 4.83
Debt Equity	KRW 0.21
Debt FCF	KRW 3.63
Equity	KRW 101.2B
Interest Coverage	2.25
Liabilities	KRW 42.2B
Long Term Assets	KRW 62.9B
Long Term Liabilities	KRW 5.5B
Net Cash	KRW -6.1B
Net Cash By Market Cap	KRW -2.76
Net Debt EBITDA	KRW 1.42
Net Debt Equity	KRW 0.06
Net Debt FCF	KRW 1.07
Tangible Book Value	KRW 98.9B
Tangible Book Value Per Share	KRW 4,217
WACC	8.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.2
Inventory Turnover	3
Net Working Capital	KRW 50B
Quick ratio	1.62
Working Capital	KRW 43.8B
Working Capital Turnover	KRW 2.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 30
Dividend Years	3
Dividend Yield	0.38%
Ex Div Date	2026-03-03
Last Dividend	KRW 30
Payout Frequency	Annual
Payout Ratio	62.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	83.67%
1Y total return	142.3%
200-day SMA	6,746.7
3Y total return	55.85%
50-day SMA	9,149.6
50-day SMA vs 200-day SMA	50over200
5Y total return	17.25%
All Time High	15,960
All Time High Change	-49.87%
All Time High Date	2026-02-13
All Time Low	747.6
All Time Low Change	970.15%
All Time Low Date	1992-08-17
ATR	458.2
Beta	0.84
Beta1y	1.19
Beta2y	0.6
Ch YTD	-6.1
High	8,430
High52	15,960
High52 Date	2026-02-13
High52ch	-49.87%
Low	7,900
Low52	3,260
Low52 Date	2025-05-08
Low52ch	145.4%
Ma50ch	-12.56%
Price vs 200-day SMA	18.58%
RSI	37
RSI Monthly	59.72
RSI Weekly	47.36
Sharpe ratio	1.34x
Sortino ratio	3.01
Total Return	0.29%
Tr YTD	-5.87
Tr15y	640.43%
Tr1m	-4.76%
Tr1w	-6.87%
Tr3m	-32.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 2.2B
Operating Income Growth5 Y	-3.69
Operating margin	2.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,895,330%
Net Borrowing	-8,536,120,240
Shares Insiders	26.39%
Shares Institutions	0.29%
Shares Out	27,677,704
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 5.7B
Average Volume	467,030.05x
Bv Per Share	4,294.6
CAPEX	KRW -2.2B
Ch10y	65.29
Ch15y	497
Ch1m	-4.76
Ch1w	-6.87
Ch1y	141.7
Ch20y	268.7
Ch3m	-32.66
Ch3y	52.67
Ch5y	13.48
Ch6m	121.6
Change	0%
Change From Open	0
Close	8,000
Days Gap	0
Depreciation Amortization	2,110,718,180
Dollar Volume	4,325,112,000
EBIT	KRW 2.2B
EBITDA	KRW 4.3B
EPS	KRW 60.34
F Score	6
FCF	KRW 5.7B
FCF Per Share	KRW 206
Financing CF	-9,417,821,600
Fiscal Year End	November
Founded	1,965
Graham Number	2414.61087
Graham Upside	-69.82
Income Tax	KRW -308.8M
Investing CF	-713,017,140
Is Primary Listing	1
Last Report Date	2013-11-30
Last Split Date	2008-03-13
Last Split Type	Forward
Lynch Fair Value	KRW 302
Lynch Upside	-96.23
Ma150	7,685.8
Ma150ch	4.09%
Ma20	8,534
Ma20ch	-6.26%
Net CF	-2,179,752,980
Open	8,000
P FCF Ratio	38.78
P OCF Ratio	27.85
Payment Date	2026-03-19
Position In Range	18.87
Ppne	33,345,927,130
Price Date	2026-05-08
Price EBITDA	KRW 51.52
Ptbv Ratio	2.24
Relative Volume	1.16x
Revenue	108,135,474,550x
Tax By Revenue	-0.29x
Tr20y	420.8%
Tr6m	122.17%
Volume	540,639
Z Score	2.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/004310 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$30.0 annual per share

Payout ratio

+62.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2026-03-03

Performance

KRX/004310 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/004310?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+26.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/004310 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.0

Neutral momentum band

Price vs 200-day MA

+18.6%

50/200-day relationship not available

Beta (5Y)

0.84

Moves roughly with the market

Sharpe ratio

1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/004310

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/004310 stock rating?

krx/004310 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/004310 analysis?

The full report lives at /stocks/krx/004310/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/004310?

The latest report frames krx/004310 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/004310 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.